Back to search

United Kingdom· GB-APID-37364711000001106

Mestinon 60mg tablets

A pyridostigmine product containing pyridostigmine, registered in United Kingdom by CST Pharma Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC N07AA02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedMestinon 60mg tabletsATCN07AA02REGISTER NO.GB-APID-3736471100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Pyridostigmine is registered in 16 of 19 countries.

Countries holding a registration under ATC N07AA02 (pyridostigmine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Pyridostigmine · ATC N07AA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyridostigmine costs, country by country.

Normalised to the WHO defined daily dose (0.18 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Pyridostigmine · price per daily dose (0.18 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.06
  • FR France$1.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Pyridostigmine
Manufacturer
CST Pharma Ltd
Country
United Kingdom (GB)
ATC code
N07AA02
ATC class
Pyridostigmine
Defined daily dose
0.18 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5055946801575

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

106 interactions on record for pyridostigmine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pyridostigmine · interactions on record

106 records

  • 2 severe
  • 56 moderate
  • 48 info

Most severe, free to view

  • SiponimodL04AA42severe
  • SiponimodL04AE03severe
  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyridostigmine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyridostigmine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Mestinon
  • Belgium · Mestinon
  • Bulgaria · Калимин
  • Czechia · Mestinon
  • Germany · Amindan, Kalymin
  • Denmark · Mestinon, Pyridostigminbromid Orifarm
  • Estonia · Kalymin, Mestinon
  • Spain · Mestinon
  • Finland · Mestinon
  • France · Mestinon, Mestinon Lp
  • Greece · Mestinon
  • Croatia · Mestinon 60
  • Hungary · Mestinon
  • Ireland · Mestinon
  • Italy · Mestinon
  • Luxembourg · Mestinon
  • Latvia · Kalymin 60 N, Mestinon
  • Malta · Mestinon
  • Netherlands · Mestinon, Mestinon 60
  • Norway · Mestinon
  • Poland · Mestinon, Stygmistanon
  • Portugal · Mestinon
  • Romania · Mestinon
  • Sweden · Mestinon, Pyridostigmin Orifarm
  • Slovenia · Mestinon
  • Slovakia · Mestinon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa25e044-2218-45a4-941d-c391fcacaa22
GET /v1/drugs/aa25e044-2218-45a4-941d-c391fcacaa22?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "37364711000001106",
  "desc": "Mestinon 60mg tablets (CST Pharma Ltd)",
  "form": "Oral tablet",
  "vpid": "42041011000001103",
  "source": "dmd",
  "vtm_id": "777367009",
  "strength": "60 mg",
  "substance": "Pyridostigmine",
  "ingredient": "Pyridostigmine bromide",
  "supplier_code": "24059811000001102"
}

See everything about pyridostigmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.